Walleye Capital’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-108
Closed -$9.56K 4321
2025
Q4
$8.68K Sell
108
-442
-80% -$37K ﹤0.01% 4304
2025
Q3
$53.7K Buy
+550
New +$44.3K ﹤0.01% 3980
2025
Q2
Sell
-94,169
Closed -$5.37M 4435
2025
Q1
$4.68M Buy
94,169
+92,739
+6,485% +$5.86M 0.02% 830
2024
Q4
$99.9K Sell
1,430
-3,368
-70% -$280K ﹤0.01% 4143
2024
Q3
$503K Buy
4,798
+4,451
+1,283% +$521K ﹤0.01% 3297
2024
Q2
$49.3K Sell
347
-11,154
-97% -$1.29M ﹤0.01% 4931
2024
Q1
$1.28M Buy
11,501
+8,470
+279% +$1.01M ﹤0.01% 2349
2023
Q4
$393K Buy
+3,031
New +$418K ﹤0.01% 3129
2022
Q3
Sell
-4,288
Closed -$235K 3187
2022
Q2
$235K Buy
+4,288
New +$248K 0.01% 1443

Other funds holding ACLS

Walleye Capital's ACLS Position: Q1 2026 in Review

Walleye Capital sold out of Axcelis (ACLS) in Q1 2026, closing a stake of 108 shares — an estimated $9.56K sold.

Walleye Capital first reported a position in ACLS in Q2 2022 and held it in 9 quarters. The position peaked at $4.68M in Q1 2025. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Walleye Capital reported no remaining Axcelis position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 108 Axcelis shares in Q1 2026, an estimated $9.56K.
  • Walleye Capital first reported a position in Axcelis in Q2 2022 and held it in 9 quarters.
  • Walleye Capital's Axcelis position peaked at $4.68M in Q1 2025.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.